• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EUROSETS S.R.L. ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EUROSETS S.R.L. ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number US5062
Device Problems Infusion or Flow Problem (2964); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thromboembolism (2654)
Event Date 05/23/2020
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Event Description
It was reported that the amg oxygenator clotted.The patient returned to the operating room to reposition cannulae.The amg oxygenator was replaced with a quadrox.
 
Event Description
It was reported the patient was symptomatic but not injured during the event.
 
Manufacturer Narrative
Section d4, h5, h8: correction.Section a2, a3, a4, h4: additional information.Manufacturer's investigation conclusion: the evaluation of the returned device confirmed the report that the oxygenator clotted.The eurosets amg pmp oxygenator, lot number 6136406, was returned to abbott and an initial visual inspection was performed.The device was returned filled with blood.Visual inspection of the oxygenator revealed no obvious damage to the external housing, ports, or fibers.No blood was observed within the top or bottom orange housing.The oxygenator was forwarded to the external manufacturer eurosets for technical analysis.Following washing and sterilization, a functional test was performed.The pressure drops measured across the oxygenator during the test were found to be greater than the technical specifications.Examination of the polymethylpentene (pmp) fibers showed that they were partially clotted with evidence of red clots.Clotting of the pmp membrane during patient support could result in a drop in partial pressure of oxygen (po2) levels.A specific cause for the observed clotting could not be conclusively determined and could not be correlated to a device-related issue.However, the reported information indicated that the partial thromboplastin time (ptt) during patient support ranged from 45-60 seconds.Based on international guidelines, the manufacturer suggests maintaining a ptt range of around 61-75 seconds.The eurosets amg pmp instructions for use (ifu) is currently available.The production documentation for amg pmp oxygenator, lot number 6136406, was reviewed by the external manufacturer and showed that all tests from the production process were compliant with the technical specifications.Under the list of warnings, the ifu warns that during the extracorporeal circulation (ecc) a backup oxygenator is necessary.Under the list of precautions, the ifu cautions that a strict anticoagulation protocol should be followed and anticoagulation should be routinely monitored during all procedures.The benefit of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.Adequate heparinization must be maintained before and during bypass.The "priming and recirculation procedure" section warns to check the correct dosage of anticoagulant in the system before starting the bypass.The "bypass start" section states to check that anticoagulation level (act) is appropriate before starting the procedure.The "during bypass" warns that the act (activated coagulation time) must always be longer than or equal to 480 seconds in order to ensure adequate anticoagulation of the extracorporeal circuit.Under the section titled "oxygenator replacement", this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine that the safety of the patient may be compromised, (insufficient oxygenator performance, leaks, abnormal blood parameters etc.), follow the procedure outlined in the ifu for oxygenator replacement.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
EUROSETS S.R.L.
strada statale 12, n°143
medolla, modena 41036
IT  41036
MDR Report Key10180058
MDR Text Key196055316
Report Number2916596-2020-03238
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K141492
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2023
Device Model NumberUS5062
Device Catalogue NumberUS5062
Device Lot Number6136406
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/10/2020
Was the Report Sent to FDA? No
Date Manufacturer Received11/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age78 YR
Patient Weight69
-
-